The Trump administration on Thursday rolled out a much-anticipated deal with drugmakers Eli Lilly and Novo Nordisk that aims ...
Analysts say that while the deal is a positive for the stock, it has already been priced in and investors are now resorting to profit booking.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback